CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 24.59

Change

-0.17 (-0.69)%

Market Cap

USD 0.28B

Volume

4.98K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.13 (+0.25%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.30%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.05 (+0.17%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.08 (+0.29%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.15 (+0.61%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.96 (+0.65%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.50%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.16 (+0.30%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.60 (+0.11%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.05 (+0.20%)

USD 79.79B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.08% 82% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.08% 81% B- 79% B-
Trailing 12 Months  
Capital Gain 13.34% 63% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.34% 62% D 63% D
Trailing 5 Years  
Capital Gain 44.31% 67% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.31% 65% D 65% D
Average Annual (5 Year Horizon)  
Capital Gain 3.17% 47% F 46% F
Dividend Return 3.42% 47% F 45% F
Total Return N/A 7% C- 13% F
Risk Return Profile  
Volatility (Standard Deviation) 20.13% 20% F 32% F
Risk Adjusted Return 16.98% 38% F 40% F
Market Capitalization 0.28B 55% F 49% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.